COVID-19 vaccine effectiveness in people with substance use disorder.

Lancet Psychiatry

National Clinical Research Center for Mental Disorders, Peking University Sixth Hospital and NHC Key Laboratory of Mental Health, Peking University Institute of Mental Health, Peking University, Beijing 100083, China. Electronic address:

Published: June 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151030PMC
http://dx.doi.org/10.1016/S2215-0366(23)00149-9DOI Listing

Publication Analysis

Top Keywords

covid-19 vaccine
4
vaccine effectiveness
4
effectiveness people
4
people substance
4
substance disorder
4
covid-19
1
effectiveness
1
people
1
substance
1
disorder
1

Similar Publications

Prebunking can be used to pre-emptively refute conspiracy narratives. We developed a new approach to prebunking - fighting fire with fire - which introduces a plausible 'meta-conspiracy' suggesting that conspiracy theories are deliberately spread as part of a wider conspiracy. In two preregistered intervention studies, prebunking specific COVID-19 vaccine (Study 1, N = 720) and climate change (Study 2, N = 1077) conspiracy theories (e.

View Article and Find Full Text PDF

Young adults in their 20s have shown slower uptake of COVID-19 vaccines relative to older adults, potentially endangering themselves and their communities. Despite this, little vaccine communication has specifically targeted this age group. This study explored why "20-somethings" in British Columbia (BC), Canada delayed COVID-19 vaccination, and how to better encourage their vaccine uptake.

View Article and Find Full Text PDF

Adverse events associated with COVID-19 vaccination or diagnosis among pregnant and non-pregnant women in the United States, 2021-2022.

Int J Infect Dis

September 2025

University of San Francisco, Department of Nursing and Health Professions, San Francisco, California, United States; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology, Fielding School of Public Health, University of California, Los A

Objectives: To quantify the incidence of adverse events given COVID-19 vaccination and COVID-19 diagnosis in women of reproductive age; to examine pregnancy as a potential risk modifier.

Methods: An exposure-matched cohort study of >1 million women, 11 December 2020-30 September 2022, United States. COVID-19 vaccination, COVID-19 diagnoses, and medically-attended adverse events - including immunologic, neurologic, cerebrovascular, thromboembolic, cardiovascular, respiratory, thrombocytopenic and coagulative events - were identified from inpatient and outpatient medical claims.

View Article and Find Full Text PDF

Objectives: Contribute to data on the long-term real-world effectiveness of the BNT162b2 vaccine efficacy (VE) in adolescents.

Study Design: This observational study from July 2021 to June 2022 was designed to emulate a target trial.

Methods: Fully vaccinated adolescents 12-15 years of age were matched to unvaccinated adolescents.

View Article and Find Full Text PDF

Vaccine safety surveillance systems are vital for the post-market safety monitoring of novel and well-established vaccines, given the sample size, representativeness and follow-up time in clinical trials. The introduction of COVID-19 vaccines during the SARS-CoV-2 pandemic presented unprecedented challenges for safety surveillance. Here, we discuss methodologic considerations for epidemiologic study design and real world data for passive and active surveillance systems for COVID-19 vaccines in the United States (U.

View Article and Find Full Text PDF